Updated:
WearLinq
WearLinq is a San Francisco-based company founded in 2020. It offers digital healthcare solutions centered on ambulatory electrocardiogram (ECG) monitoring.
WearLinq
WearLinq is a San Francisco-based company founded in 2020. It offers digital healthcare solutions centered on ambulatory electrocardiogram (ECG) monitoring. WearLinq has secured $14.7 million in total funding.
General information
Firm type
other
Location
Region
North America
Country
United States
City
San Francisco
Corporate office
San Francisco, CA, United States
Sector focus
Frequently asked questions
What regulatory clearance does WearLinq's eWave device hold?
The eWave 6-lead ECG monitor holds FDA clearance as a wireless, continuous, multimodal cardiac monitoring device. The company markets it specifically as the first FDA-cleared wireless continuous 6-lead ECG multimodal monitor. The clearance covers ambulatory monitoring applications including Extended Holter modalities.
How does WearLinq's clinical data platform work?
WearLinq's LiveLinq platform provides clinicians with full-disclosure access to the entire patient ECG study. The system delivers all waveform data — not just triggered episodes — and supports configurable display layouts and a zoom feature for detailed signal-level analysis. The platform is designed for use across all monitoring modalities, including Extended Holter, and generates STAT reports on a daily basis.
Where is WearLinq headquartered and in which markets does it operate?
WearLinq is headquartered in San Francisco, California. The company markets its eWave device in the United States, where it holds FDA clearance. The firm has not publicly disclosed international regulatory approvals or commercial operations outside the US market.
What is WearLinq's known funding status?
WearLinq has not publicly disclosed its venture funding history, total capital raised, or institutional investors. The firm operates as a private company and does not list financial backers on its website or in publicly available materials as of early 2026.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on investors?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: